Founded with a mission to innovate in cerebrospinal fluid (CSF) management, Anuncia Medical aims to prevent shunt failure and reduce the need for revision brain surgeries. The company offers the ReFlow™ System Mini, an FDA Breakthrough Device designed to improve the reliability of CSF shunts. Anuncia focuses on providing advanced medical solutions to patients suffering from hydrocephalus and other related conditions, positioning itself at the forefront of neurosurgical innovation.
Anuncia Medical has garnered attention through its association with notable healthcare professionals and investors committed to advancing medical technology. The company's key achievement includes receiving the FDA Breakthrough Device designation for its ReFlow™ System Mini, highlighting its potential to significantly impact patient care. By addressing critical issues in CSF management, Anuncia Medical is making strides in improving patient outcomes and reducing the frequency of invasive brain surgeries.
